The Next Decade of Pharma: How India’s Pharmaceutical Sector is set to transform by 2035

The Next Decade of Pharma: How India’s Pharmaceutical Sector is set to transform by 2035

By Amar Products August 25, 2025

India’s pharmaceutical sector — already known as the “Pharmacy of the World” — is entering a powerful growth phase. Over the next 10 years, the industry is expected to expand in scale, sophistication, and global influence, driven by rising healthcare demands, digital innovation, and global trust in India’s manufacturing capabilities.

Let’s explore the key trends, opportunities, and what it means for pharma professionals and companies.

India’s Pharma Sector: A Snapshot

• Current Value (2025): Approx. $65 billion
• Projected Value (2035): Estimated to cross $130–150 billion
• Global Rank: 3rd largest by volume, 14th by value
• Export Markets: 200+ countries including the US, Africa, Southeast Asia, Latin America

This growth is not just in numbers, but in technology, innovation, and credibility.

What’s Driving This 10-Year Growth?

1. Healthcare Access in Emerging Markets

As countries in Africa, Southeast Asia, and Latin America improve healthcare infrastructure, demand for affordable generic medicines is surging — and India is perfectly positioned to supply them.

At Amar Products, we’re already seeing demand rise in Zazibona and COMESA-regulated countries.

2. Digital & AI-Driven Drug Manufacturing

Automation, AI-based formulation design, and smart factories are being adopted faster than ever.
Expect paperless batch records, predictive QC, and data-driven R&D to become the norm.

3. Rising Demand for Chronic & OTC Treatments

With lifestyle diseases on the rise, India’s OTC, pain relief, dermatology, and nutraceutical segments will grow fast.

Topical treatments like pain gels (such as our own DardRest) are expected to become household essentials.

4. Contract & Third-Party Manufacturing Boom

Startups and marketing companies are focusing on branding and distribution, outsourcing manufacturing to WHO-GMP certified units.

Companies like Amar Products, with third-party capacity and global compliance, are set to benefit greatly.

5. Focus on Quality & Certifications

Global buyers now demand WHO-GMP, EU-GMP, ISO, and even PICS certifications.
This will push manufacturers to improve facility standards, documentation, and sustainability.

🌍 India’s Role as a Global Pharma Hub

By 2035, India may not just be a supplier — but a center of formulation innovation, clinical research, and biotech development. With support from the PLI (Production Linked Incentive) scheme and government-backed export incentives, Indian companies will expand faster into regulated markets.

🧪 Opportunities for Indian Pharma Professionals

• R&D roles in formulation and stability
• Regulatory affairs and international documentation
• Export business development
• Digital transformation of pharma operations
• Pharmacovigilance and data compliance

🏭 How Amar Products is Preparing for the Future

At Amar Products, we understand that the future will demand:

• WHO-GMP-compliant manufacturing
• Transparent documentation and batch traceability
• Green initiatives like ETP plants, waste segregation, and energy-efficient operations
• Strong third-party partnerships with emerging pharma brands

We aim to grow sustainably, serve new markets, and support healthcare innovation over the next decade.

Final Takeaway

The next 10 years will redefine the Indian pharmaceutical sector — not just in size, but in reputation, responsibility, and resilience.
Whether you’re a pharma professional, investor, or contract partner, now is the time to prepare, innovate, and align with this exciting future.